May premium magazine: Early warnings and near misses

essential biosecurity reading

Essential reading on lab leaks and gain-of-function research

By Matt Field | Disruptive Technologies

Members of the World Health Organization (WHO) team investigating the origins of the COVID-19 coronavirus arrive by car at the Wuhan Institute of Virology on February 3. (Photo by HECTOR RETAMAL/AFP via Getty Images)

The origin of COVID: Did people or nature open Pandora’s box at Wuhan?

By Nicholas Wade | Biosecurity, Investigative Reporting

A duck receives a vaccine.

The pandemic risk of an accidental lab leak of enhanced flu virus: unacceptably high

By Lynn Klotz | Analysis, Biosecurity

This scanning electron microscope image shows SARS-CoV-2 in yellow.

Did the SARS-CoV-2 virus arise from a bat coronavirus research program in a Chinese laboratory? Very possibly.

By Milton Leitenberg | Biosecurity

Tedros Adhanom Ghebreyesus at a press conference.

Will the WHO call for an international investigation into the coronavirus’s origins?

By Filippa Lentzos | Biosecurity

closeup of coronavirus through microscope

Let evidence, not talk radio, determine whether the outbreak started in a lab

By Ali Nouri | Biosecurity, Opinion

A biosafety level 4 lab.

Experts know the new coronavirus is not a bioweapon. They disagree on whether it could have leaked from a research lab

By Matt Field | Biosecurity

Hot zone in the heartland?

By Elisabeth Eaves | Biosecurity, Investigative Reporting

800px-Influenza_virus_research.jpg

Is there a role for the Biological Weapons Convention in oversight of lab-created potential pandemic pathogens?

By Lynn Klotz | Analysis, Biosecurity, Disruptive Technologies

Mutate a flu…Say WHAT?

By | What’s New at the Bulletin

A CDC staff microbiologist examines reconstructed 1918 Pandemic Influenza Virus contained at a Biosafety Level 3-enhanced lab. Photo credit: Photo Credit: James Gathany/CDC

Human error in high-biocontainment labs: a likely pandemic threat

By Lynn Klotz | Analysis, Biosecurity, Disruptive Technologies

Supplementary material for “Human error in high-biocontainment labs: a likely pandemic threat”

By Lynn Klotz | Biosecurity, Disruptive Technologies